Cargando…

ALLN-177, oral enzyme therapy for hyperoxaluria

PURPOSE: To evaluate the potential of ALLN-177, an orally administered, oxalate-specific enzyme therapy to reduce urine oxalate (UOx) excretion in patients with secondary hyperoxaluria. METHODS: Sixteen male and female subjects with both hyperoxaluria and a kidney stone history were enrolled in an o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lingeman, James E., Pareek, Gyan, Easter, Linda, Pease, Rita, Grujic, Danica, Brettman, Lee, Langman, Craig B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2019
Materias:	Urology - Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459785/ https://www.ncbi.nlm.nih.gov/pubmed/30783888 http://dx.doi.org/10.1007/s11255-019-02098-1

Ejemplares similares

Oral Treatment With an Engineered Uricase, ALLN-346, Reduces Hyperuricemia, and Uricosuria in Urate Oxidase-Deficient Mice
por: Pierzynowska, Kateryna, et al.
Publicado: (2020)

Pilot study of reloxaliase in patients with severe enteric hyperoxaluria and hyperoxalemia
por: Pfau, Anja, et al.
Publicado: (2021)

Hyperoxaluria after modern bariatric surgery: case series and literature review
por: Whitson, Jared M., et al.
Publicado: (2009)

Clinical and economic impact of primary hyperoxaluria: a retrospective claims analysis
por: Mucha, Lisa, et al.
Publicado: (2022)

Predictors of Lymphatic Complications Following Renal Transplant: A Prospective Study Involving Predominantly Living Donor Transplants From India
por: Agarwal, Nitin, et al.
Publicado: (2021)

UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer
por: Li, Shang-Ze, et al.
Publicado: (2014)

A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis
por: Kasamatsu, Hiroshi, et al.
Publicado: (2023)

Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria
por: Ariceta, Gema, et al.
Publicado: (2021)

Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Association of Virulence Markers With Resistance to Oral Antibiotics in Escherichia coli Isolates Causing Uncomplicated Community-Acquired Cystitis
por: Radera, Shruti, et al.
Publicado: (2023)

Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review
por: Yeowell, Gillian, et al.
Publicado: (2018)

Comparative efficacy and safety of oral anticoagulants for the treatment of venous thromboembolism in the patients with different renal functions: a systematic review, pairwise and network meta-analysis
por: Su, Xiaole, et al.
Publicado: (2022)

Low-Intensity Shockwave Therapy in the Treatment of Erectile Dysfunction
por: Lurz, Kelly, et al.
Publicado: (2020)

Effectiveness of cognitive behavioural therapy on quality of life in patients with prostate cancer after androgen deprivation therapy: a protocol for systematic review and meta-analysis
por: Yuan, Fan, et al.
Publicado: (2021)

Rezum Therapy for Benign Prostatic Hyperplasia: Dubai’s Initial Experience
por: Rowaiee, Rashed, et al.
Publicado: (2021)

Crystal structure of N-{N-[N-acetyl-(S)-leucyl]-(S)-leucyl}norleucinal (ALLN), an inhibitor of proteasome
por: Czerwinski, Andrzej, et al.
Publicado: (2015)

Mycobacterial Osteomyelitis of the Spine Following Intravesical BCG Therapy for Bladder Cancer
por: Mackel, Charles E, et al.
Publicado: (2016)

Prognostic Models for Renal Cell Carcinoma in the Era of Immune Checkpoint Therapy
por: Parosanu, Andreea, et al.
Publicado: (2022)

Atypical Presentation of a Urachal Carcinoma as an Enterocutaneous Fistula
por: Martins, Ana Rita, et al.
Publicado: (2022)

Preoperative Testosterone Therapy Prior to Surgical Correction of Hypospadias: A Review of the Literature
por: Krishnan, Arvind, et al.
Publicado: (2016)

Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer
por: Delgado, Jessica, et al.
Publicado: (2022)

A Comparison Between Silodosin and Tamsulosin for Medical Expulsive Therapy of Distal Ureteric Calculus
por: Abdullah, Atif, et al.
Publicado: (2023)

Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias
por: Moya-Garzon, Maria Dolores, et al.
Publicado: (2021)

Evaluating variation in use of definitive therapy and risk-adjusted prostate cancer mortality in England and the USA
por: Sachdeva, Ashwin, et al.
Publicado: (2015)

The Impact of Obesity on Patient Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Koneru, Harsha, et al.
Publicado: (2016)

Sloughing Prostatic Tissue, a Rare Complication Post Rezum Therapy: A Case Report
por: Alothman, Ali, et al.
Publicado: (2020)

Vertebral Osteomyelitis Secondary to Bacillus Calmette-Guérin Instillation Therapy for Transitional Cell Carcinoma In Situ
por: Jaber, Tariq M, et al.
Publicado: (2021)

Lumbosacral Vertebral Osteomyelitis With Iliopsoas and Epidural Abscess Following Intravesical Bacillus Calmette-Guérin Therapy
por: Abbas, Anas M, et al.
Publicado: (2023)

Multifaceted self-management interventions for older women with urinary incontinence: a systematic review and narrative synthesis
por: Fu, Yu, et al.
Publicado: (2019)

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)
por: Drake, Marcus J., et al.
Publicado: (2017)

Surgical Treatment of Penile Verrucous Squamous Cell Carcinoma in an HIV-Infected Patient: A Case Report
por: Okieh, Yacoub A, et al.
Publicado: (2023)

Primary Hyperoxaluria
por: Harambat, Jérôme, et al.
Publicado: (2011)

Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis
por: Sussman, D., et al.
Publicado: (2017)

Discontinuation of alpha-blocker therapy in men with lower urinary tract symptoms: a systematic review and meta-analysis
por: van der Worp, Henk, et al.
Publicado: (2019)

Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study
por: Rosenberg, M T, et al.
Publicado: (2009)

Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer
por: White, I D, et al.
Publicado: (2015)

Paratesticular Serous Papillary Carcinoma of High Grade and Malignant Potential: A Rare Case with a Role for Adjuvant Therapy
por: Lifton, Jacob, et al.
Publicado: (2018)

Association between ischaemic bowel syndromes and androgen deprivation therapy in patients with prostate cancer: a retrospective cohort study
por: Chiang, I-Ni, et al.
Publicado: (2017)

Exploring support, experiences and needs of older women and health professionals to inform a self-management package for urinary incontinence: a qualitative study
por: Fu, Yu, et al.
Publicado: (2023)

Decision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer
por: Boyd, Kathleen A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nthb787vc8fccn2tl15ggro1t4